Pharmacare advisory committee report set to be made public
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $20.00 plus GST for four weeks. After four weeks, your payment will increase to $24.00 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
OTTAWA – The federal government is set to release a report today by the advisory committee tasked with determining how to set up a national pharmacare program.
The committee was set up last fall, after the Pharmacare Act became law, and was given a year to report back to the health minister.
The pharmacare law was something the NDP pushed for as part of its supply and confidence deal with the minority Liberal government under Justin Trudeau.
It called for an expert committee to recommend options for operating and financing a national, universal, single-payer pharmacare program.
A report by the parliamentary budget officer in 2023 estimated such a program would cost $11.2 billion more than the government currently spends on medications and other costs.
The current minority Liberal government under Prime Minister Mark Carney set aside no new funding for pharmacare in its recent budget.
This report by The Canadian Press was first published Nov. 21, 2025.